Table 7. Risk factors for hypoxemia in children infected with Mycoplasma pneumoniae, Ohio, USA, 2015–2019*.
| Characteristic | Univariate analysis |
Multivariable analysis |
|||
|---|---|---|---|---|---|
| OR (95% CI) | p value | aOR (95% CI) | p value | ||
| Female sex | 1.117 (0.68–1.85) | 0.6645 | |||
| Age, y | 0.964 (0.91–1.02) | 0.194 | |||
| Underlying conditions | 3.279 (1.94–5.54) | <0.0001 | 3.46 (2–5.98) | <0.0001 | |
| Any previous visit | 3.202 (1.8–5.69) | <0.0001 | 1.77 (0.94–3.33) | 0.0796 | |
| Macrolide resistance | 1.236 (0.34–4.54) | 0.75 | 0.91 (0.22–3.72) | 0.8965 | |
| Abnormal respiratory examination | 25.288 (6.98–91.64) | <0.0001 | |||
| Previous treatment with antimicrobial drugs | 2.43 (1.45–4.07) | 0.0007 | 2.35 (1.18–4.68) | 0.0151 | |
| Previous nonmacrolide antimicrobial drugs | 2.129 (1.27–3.58) | 0.0043 | |||
| Positive viral test | 0.902 (0.46–1.79) | 0.7683 | |||
| MRMp and viral positive | 0.957 (0.16–5.81) | 0.9618 | |||
*Bold type indicates statistical significance. aOR, adjusted odds ratio; MRMp: macrolide-resistant Mycoplasma pneumoniae; OR, odds ratio.